Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes

被引：0
|
作者：
Meidong Zhu
Jamie K. Chew
Geoffrey K. Broadhead
Kehui Luo
Nichole Joachim
Thomas Hong
Adil Syed
Andrew A. Chang
机构：
[1] Sydney Institute of Vision Science,Save Sight Institute
[2] The University of Sydney,Statistics Department
[3] Macquarie University,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2015年 / 253卷
关键词：
Ranibizumab; Neovascular age-related macular degeneration (nAMD); As-needed treatment model; Five-year treatment; Exudative age-related macular degeneration; Wet macular degeneration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1217 / 1225
页数：8
相关论文
共 50 条
  • [41] Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatment
    Bloch, Sara B.
    la Cour, Morten
    Sander, Birgit
    Hansen, Louise K. H.
    Fuchs, Josefine
    Lund-Andersen, Henrik
    Larsen, Michael
    ACTA OPHTHALMOLOGICA, 2013, 91 (01) : 42 - 47
  • [42] Comparison of outcomes after switching treatment from intravitreal bevacizumab or ranibizumab to aflibercept in neovascular age-related macular degeneration
    Venzara, Frank
    Mason, John
    Glover, Jay
    McGwin, Gerald
    Huisingh, Carrie
    Friedman, Duncan
    Feist, Richard
    Thomley, Martin
    Albert, Michael
    Price, Natalie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [43] Association of Keratin 8 Level in Aqueous Humor With Outcomes of Intravitreal Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration
    Shin, Joo Youn
    Lee, Jonghyun
    Park, Jinkyu
    Kim, Min
    Chung, Hyewon
    Byeon, Suk Ho
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2022, 11 (01):
  • [44] THREE YEAR TREATMENT PATTERNS OF RANIBIZUMAB AND AFLIBERCEPT FOR THE MANAGEMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN ROUTINE CLINICAL PRACTICE IN THE USA
    Leteneux, C.
    Milnes, F.
    Skelly, A.
    Bezlyak, V
    Paschen, E.
    Sagkriotis, A.
    VALUE IN HEALTH, 2016, 19 (07) : A574 - A574
  • [45] Clinical Outcomes of Intravitreal Brolucizumab Injection for Refractory Neovascular Age-related Macular Degeneration
    Lee, Jun Young
    Park, No Hae
    Kwon, Han Jo
    Park, Sung Who
    Byon, Ik Soo
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2024, 65 (09): : 596 - 604
  • [46] Visual hallucinations after intravitreal injection of ranibizumab in neovascular age-related macular degeneration
    Tan, C. S. H.
    EYE, 2011, 25 (10) : 1374 - 1374
  • [47] Bimonthly Ranibizumab for Neovascular Age-Related Macular Degeneration
    Cohen, Salomon Yves
    Maloberti, Bertrand
    Fajnkuchen, Franck
    Nghiem-Buffet, Sylvia
    Delahaye-Mazza, Corinne
    Grenet, Typhaine
    Quentel, Gabriel
    OPHTHALMOLOGICA, 2014, 231 (02) : 80 - 85
  • [48] Ranibizumab for neovascular age-related macular degeneration - Reply
    Rosenfeld, Philip J.
    Brown, David M.
    Schneider, Susan
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 749 - 750
  • [49] RETINAL PIGMENT EPITHELIAL TEAR AFTER INTRAVITREAL RANIBIZUMAB TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Cho, Han Joo
    Kim, Hyoung Seok
    Yoo, Seul Gi
    Han, Jung Il
    Lew, Young Ju
    Cho, Sung Won
    Lee, Tae Gon
    Kim, Jong Woo
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (10): : 1851 - 1859
  • [50] Early Multifocal Electroretinogram Findings during Intravitreal Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration
    Campa, Claudio
    Hagan, Richard
    Sahni, Jayashree N.
    Brown, Malcolm C.
    Beare, Nicholas A. V.
    Heimann, Heinrich
    Harding, Simon P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (06) : 3446 - 3451
12345